Cargando…
A network meta-analysis of maintenance therapy in chronic lymphocytic leukemia
BACKGROUND: Chronic lymphocytic leukemia (CLL) is incurable through conventional chemoimmunotherapy regimens. Despite durable responses to front-line therapy and sustained remission rates in patients with CLL, a majority of patients eventually relapse in 5 years of initial treatment. The depth of th...
Autores principales: | Lee, Cho-Hao, Chen, Po-Huang, Lin, Chin, Wang, Chieh-Yung, Ho, Ching-Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988939/ https://www.ncbi.nlm.nih.gov/pubmed/31995577 http://dx.doi.org/10.1371/journal.pone.0226879 |
Ejemplares similares
-
Treatment Outcomes of Novel Targeted Agents in Relapse/Refractory Chronic Lymphocytic Leukemia: A Systematic Review and Network Meta-Analysis
por: Chen, Po-Huang, et al.
Publicado: (2019) -
Effect of Lenalidomide Maintenance in Chronic Lymphocytic Leukemia: A Meta-Analysis and Trial-Sequential Analysis
por: Yu, Tsung-Ying, et al.
Publicado: (2022) -
PB1873: EFFECTS OF LENALIDOMIDE MAINTENANCE IN CHRONIC LYMPHOCYTIC LEUKEMIA: A TRIAL-SEQUENTIAL ANALYSIS
por: Lee, C.-H., et al.
Publicado: (2022) -
Endocrine therapies in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative, pretreated, advanced breast cancer: A network meta-analysis
por: Lee, Cho-Hao, et al.
Publicado: (2020) -
New emerging therapies in the management of chronic lymphocytic leukemia
por: Li, Xiao-Lin, et al.
Publicado: (2016)